|
|
|
|
|
by Uberphallus
1677 days ago
|
|
Yeah, but this scale of documentation production is unprecedented. A lot of cash was dumped into fast and extensive R&D, trials and production scaling because of the urgency of the situation, and along comes an insane documentation backlog. To put in perspective, the original HPV vaccine R&D and trial spanned over 7 years with 25,000 patients (of which only 20,000 women), and assuming the documentation was provided to the FDA as it was produced, it could be FOIA'd relatively quickly. Pfizer/BioNTech did the same, with almost double the patients, in just over 6 months. |
|